Desheng Weng
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
Papers in
- Oncology 23
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 5
- Cancer-related Molecular Pathways 4
-
- Heat shock proteins research 5
- RNA modifications and cancer 4
- Co-authors
- Jianlin Gong (9 shared papers)Stuart K. Calderwood (9 shared papers)Qiuzhong Pan (28 shared papers)Baizheng Song (6 shared papers)Jian‐Chuan Xia (26 shared papers)Shigeo Koido (4 shared papers)Zhengrong Wu (5 shared papers)Jingjing Zhao (16 shared papers)
- Journals
- Molecular Carcinogenesis (4 papers)Journal of Clinical Oncology (4 papers)Breast Cancer Research (2 papers)The Journal of Immunology (2 papers)Clinical & Translational Immunology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Desheng Weng
59 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 86
- Immunology 339
- Oncology 391
- Cancer Research 152
- Molecular Biology 602
- Cell Biology 115
Countries citing papers authored by Desheng Weng
This map shows the geographic impact of Desheng Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Desheng Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Desheng Weng more than expected).
Fields of papers citing papers by Desheng Weng
This network shows the impact of papers produced by Desheng Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Desheng Weng. The network helps show where Desheng Weng may publish in the future.
Co-authors
The 25 scholars most cited alongside Desheng Weng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 59 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 91 | |
| 2 | 2009 | 84 | |
| 3 | 2021 | 71 | |
| 4 | 2020 | 66 | |
| 5 | 2013 | 56 | |
| 6 | 2012 | 54 | |
| 7 | 2017 | 50 | |
| 8 | 2013 | 42 | |
| 9 | 2010 | 42 | |
| 10 | 2022 | 36 | |
| 11 | 2009 | 34 | |
| 12 | 2018 | 28 | |
| 13 | 2017 | 28 | |
| 14 | 2009 | 26 | |
| 15 | 2019 | 26 | |
| 16 | Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array. | 2010 | 25 |
| 17 | 2022 | 24 | |
| 18 | 2015 | 23 | |
| 19 | 2010 | 23 | |
| 20 | 2023 | 21 |
About Desheng Weng
Desheng Weng is a scholar working on Oncology, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 59 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Cell Function and Interaction (6 papers), Toxin Mechanisms and Immunotoxins (5 papers), Heat shock proteins research (5 papers), CAR-T cell therapy research (5 papers), Cancer-related Molecular Pathways (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Immunology (339 citations), Oncology (391 citations), Cancer Research (152 citations), Molecular Biology (602 citations) and Cell Biology (115 citations). Desheng Weng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Jianlin Gong, Stuart K. Calderwood, Qiuzhong Pan, Baizheng Song, Jian‐Chuan Xia, Shigeo Koido, Zhengrong Wu, Jingjing Zhao, Lirong Wu and Yan Tang. Their work appears in journals such as Molecular Carcinogenesis, Journal of Clinical Oncology, Breast Cancer Research, The Journal of Immunology and Clinical & Translational Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.